Disease/Infection News

RSS

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Researchers generated six human monoclonal antibodies that prevented infection.

17 May 2023

Updated evidence suggests that masks may be associated with a reduction in risk for SARS-CoV-2 infection

Researchers presented updated evidence of the effectiveness of masks in preventing SARS-CoV-2.

17 May 2023

Are masks effective in the protection against COVID-19?

Researchers discussed the efficacy of masks in preventing coronavirus disease 2019 (COVID-19).

17 May 2023

Reviving a forgotten antibiotic: Old drug shows new promise against superbugs

Research discusses the activity spectrum of nourseothricin and its components, S-F and S-D, against drug-resistant, gram-negative pathogens. S-F showed promising activity against NDM-1-expressing Klebsiella pneumoniae Nevada strain with minimal toxicity, and it probes the A-decoding site potentially accounting for its miscoding activity.

17 May 2023

Long-ignored antibiotic could help fight against multi-drug resistant bacteria

"The end of modern medicine as we know it." That's how the then-director general of the World Health Organization characterized the creeping problem of antimicrobial resistance in 2012.

16 May 2023

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Research examines the impact of long-Covid syndrome on the health-related quality of life (HRQoL) of patients with mild or moderate SARS-CoV-2 infections. It reveals significant impairments in physical and mental health, emphasizing the need for long-term surveillance and support for affected individuals.

16 May 2023

Machine learning reveals sex-specific Alzheimer's risk genes

Research explores sex-specific gene associations in Alzheimer's disease using a machine-learning approach. It reveals immune response pathways in both sexes and stress-response pathways in males, highlighting potential biomarkers and therapeutic targets for personalized treatments.

16 May 2023

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

Researchers investigated the genetic origin, distribution patterns, and antigenicity of novel AIVs.

16 May 2023

The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

Researchers isolated a novel virus of the Orthonairovirus genus.

16 May 2023

A flexible living approach is needed to maintain NICE’s long-term effects of COVID-19 (LTE) guidelines

Researchers described the establishment, execution, and assessment of a flexible living strategy.

16 May 2023

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Researchers described rapid mutagenesis and rescue of SARS-CoV-2 variants without cloning.

16 May 2023

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Research highlights the effectiveness of serosurveillance in monitoring SARS-CoV-2 exposure within a population. It emphasizes the importance of considering demographic variations in antibody prevalence to inform targeted public health strategies.

16 May 2023

Does obstructive sleep apnea increase the risk of post-acute sequelae of SARS-CoV-2?

Research paper examines the potential link between obstructive sleep apnea (OSA) and Post-Acute Sequelae of SARS-CoV-2 (PASC), the long-term effects of COVID-19. It investigates whether OSA increases the risk of more severe PASC outcomes.

15 May 2023

Rapid spread of antibiotic-resistant E. coli across Europe raises concerns

Research paper highlights the swift cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area from 2012 to June 2022. The findings emphasize the need for continued surveillance and effective measures to combat the spread of antibiotic-resistant bacteria.

15 May 2023

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.

15 May 2023

Study indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescents

Researchers discussed the presence of persistent humoral immunity among children and adolescents during COVID-19.

15 May 2023

Disease/Infection News

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Updated evidence suggests that masks may be associated with a reduction in risk for SARS-CoV-2 infection

Are masks effective in the protection against COVID-19?

Reviving a forgotten antibiotic: Old drug shows new promise against superbugs

Long-ignored antibiotic could help fight against multi-drug resistant bacteria

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Machine learning reveals sex-specific Alzheimer's risk genes

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

A flexible living approach is needed to maintain NICE’s long-term effects of COVID-19 (LTE) guidelines

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Does obstructive sleep apnea increase the risk of post-acute sequelae of SARS-CoV-2?

Rapid spread of antibiotic-resistant E. coli across Europe raises concerns

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

Study indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescents

Alcohol-based disinfectants can effectively protect against monkeypox viruses

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

SARS-CoV-2 variants show altered glycan processing

Novel arterivirus discovered in Amazonian rodents unveiling a potential viral spillover threat

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News